Low-Volatility Stocks: Stability vs. Growth

Todays episode delves into low-volatility stocks, offering stability but often falling short in growth periods. We examine Pfizer, Exponent, and Aflac, finding underperformance in their core businesses, sales trends, and earnings growth. Despite Pfizers historical profit centers, Exponents unexciting sales, and Aflacs contracting net premiums, we explore potential better opportunities elsewhere.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.